Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

(2013) Jon B. Toledo et al.   Alzheimers & Dementia

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

(2013) Judy K. Qiang et al.   ANNALS OF NEUROLOGY

Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels

(2013) Fatemeh Bandarian et al.   LIPIDS

Discontinuation of statin therapy associates with Parkinson disease: A population-based study

(2013) Y.-C. Lee et al.   NEUROLOGY

Prospective Study of Statin Use and Risk of Parkinson Disease

(2012) Xiang Gao   ARCHIVES OF NEUROLOGY

Gene–diet interactions on plasma lipid levels in the Inuit population

(2012) Iwona Rudkowska et al.   BRITISH JOURNAL OF NUTRITION

An integrated encyclopedia of DNA elements in the human genome

(2012)   NATURE

An integrated map of genetic variation from 1,092 human genomes

(2012)   NATURE

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

(2012) Chera L Maarouf et al.   NEUROLOGICAL RESEARCH

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels

(2011) Rui-Xing Yin et al.   Lipids in Health and Disease

Does vigorous exercise have a neuroprotective effect in Parkinson disease?

(2011) J. E. Ahlskog   NEUROLOGY

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

(2010) Alice S. Chen-Plotkin et al.   ANNALS OF NEUROLOGY

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice

(2010) Iliya Lefterov et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease

(2010) Terry L. Lewis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

(2010) Vivianna M Van Deerlin et al.   NATURE GENETICS

Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries

(2010) Allison Wright Willis et al.   NEUROEPIDEMIOLOGY

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease

(2010) Min Shi et al.   NEUROSCIENCE LETTERS

Genome-wide association study reveals genetic risk underlying Parkinson's disease

(2009) Javier Simón-Sánchez et al.   NATURE GENETICS

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

(2008) Michael A. Schwarzschild   ARCHIVES OF NEUROLOGY

An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis

(2008) G Koutsis et al.   Multiple Sclerosis Journal